[go: up one dir, main page]

AU2001239349A1 - Oral pharmaceutical compositions containing n-sulphonylindoline derivatives - Google Patents

Oral pharmaceutical compositions containing n-sulphonylindoline derivatives

Info

Publication number
AU2001239349A1
AU2001239349A1 AU2001239349A AU3934901A AU2001239349A1 AU 2001239349 A1 AU2001239349 A1 AU 2001239349A1 AU 2001239349 A AU2001239349 A AU 2001239349A AU 3934901 A AU3934901 A AU 3934901A AU 2001239349 A1 AU2001239349 A1 AU 2001239349A1
Authority
AU
Australia
Prior art keywords
sulphonylindoline
derivatives
pharmaceutical compositions
compositions containing
oral pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239349A
Other languages
English (en)
Inventor
Ross Blundell
Simon John Fuller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU2001239349A1 publication Critical patent/AU2001239349A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001239349A 2000-03-08 2001-03-07 Oral pharmaceutical compositions containing n-sulphonylindoline derivatives Abandoned AU2001239349A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0002949A FR2805992A1 (fr) 2000-03-08 2000-03-08 Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
FR0002949 2000-03-08
PCT/FR2001/000673 WO2001066109A1 (fr) 2000-03-08 2001-03-07 Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline

Publications (1)

Publication Number Publication Date
AU2001239349A1 true AU2001239349A1 (en) 2001-09-17

Family

ID=8847842

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239349A Abandoned AU2001239349A1 (en) 2000-03-08 2001-03-07 Oral pharmaceutical compositions containing n-sulphonylindoline derivatives

Country Status (3)

Country Link
AU (1) AU2001239349A1 (fr)
FR (1) FR2805992A1 (fr)
WO (1) WO2001066109A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2848114B1 (fr) * 2002-12-10 2006-08-04 Helvederm Sa Composition a base d'hinokitiol pour les soins d'hygiene.
EP1707197A1 (fr) * 2005-03-30 2006-10-04 Teva Pharmaceutical Industries Ltd. Compositions, contenant du fenofibrate et un mélange d'agents tensio-actifs
JP2008534586A (ja) * 2005-03-30 2008-08-28 テバ ファーマシューティカル インダストリーズ リミティド フェノフィブレートの改良された製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
FR2756736B1 (fr) * 1996-12-05 1999-03-05 Sanofi Sa Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Also Published As

Publication number Publication date
WO2001066109A1 (fr) 2001-09-13
FR2805992A1 (fr) 2001-09-14

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001250420A1 (en) Pharmaceutical compositions
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
GB0028575D0 (en) Oral pharmaceutical compositions containing cyclodextrins
AU2001274307A1 (en) Pharmaceutical compositions
AU2001248769A1 (en) Time-release coated solid compositions for oral administration
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU3752501A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2001271037A1 (en) Pharmaceutical compositions containing dds compounds
AU3556400A (en) Pharmaceutical compositions
AU2001262733A1 (en) Medicinal compositions containing propenone derivatives
HUP0301390A3 (en) Oral pharmaceutical composition containing valsartan
AU2002214324A1 (en) Medicinal compositions
AU4428000A (en) Pulse-delivery oral compositions
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
AU4304400A (en) Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
AU2001273919A1 (en) Pharmaceutical compositions
AU6460400A (en) Pharmaceutical compositions
AU1732401A (en) Medicinal compositions for oral use
AU2001270235A1 (en) Oral compositions
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU6460200A (en) Pharmaceutical compositions
AU4085201A (en) Pharmaceutical composition
AU2001290669A1 (en) Oral compositions